|
2HRZE + experimental drugs |
|
|
2HRZE 2HR |
|
|
BEAT-TB |
USAID |
|
Bedaquiline - Delamanid with MBT for MDR |
|
|
Bedaquiline - Linezolid - Levofloxacin with OBR |
|
|
Bedaquiline - Pretomanid - Linezolid |
TB Alliance |
|
Bedaquiline - Pretomanid - Linezolid - Moxifloxacin |
Médecins Sans Frontières |
|
Bedaquiline, Pretomanid, Moxifloxacin, Pyrazinamide |
TB Alliance |
|
Bedaquiline-Moxifloxacin-Linezolid-Pyrazinamide |
|
|
CC-11050, Auranofin, Everolimus, Vitamin D3 plus Rifabutin-modified TB Therapy |
The Aurum Institute NPC, Medicines Development for Global Health |
|
Delamanid with OBR |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
|
Delamanid, Bedaquiline, OPC-167832 |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
|
Delpazolid, Bedaquiline, Delamanid, & Moxifloxacin |
PanACEA |
|
INH, RIF, PZA, MOX |
|
|
Pravastatin, Rifafour, & Vitamin B6 |
|
|
Pretomanid - Moxifloxacin - Pyrazinamide Regimen |
TB Alliance |
|
Sutezolid, Bedaquiline, Delamanid, & Moxifloxacin |
PanACEA |
